Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Model of reversible cerebral ischemia in a monkey model.

Literature DB >> 14561612

Model of reversible cerebral ischemia in a monkey model.

Charles A Jungreis¹, Edwin Nemoto, Fernando Boada, Michael B Horowitz.

Abstract

We have developed a model of reversible cerebral ischemia in a high-level nonhuman primate. By using endovascular techniques, the posterior cerebral artery is permanently occluded with coils, and the ipsilateral middle cerebral artery is temporarily occluded with a balloon. The balloon can be deflated and/or removed to reestablish flow at precise time intervals. Functional imaging of the brain can be performed during occlusion and reperfusion, since the balloon can be deflated or removed in a scanner.

Entities: Disease

Mesh：

Year: 2003 PMID： 14561612 PMCID： PMC7976288

Source DB: PubMed Journal: AJNR Am J Neuroradiol ISSN： 0195-6108 Impact factor: 3.825

13 in total

1. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors: A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal: JAMA Date: 1999-12-01 Impact factor: 56.272

2. The distribution and density of reduced cerebral blood flow following acute middle cerebral artery occlusion: an experimental study by the technique of hydrogen clearance in baboons.

Authors: L Symon; E Pasztor; N M Branston
Journal: Stroke Date: 1974 May-Jun Impact factor: 7.914

3. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.

Authors: M P Marks; D C Tong; C Beaulieu; G W Albers; A de Crespigny; M E Moseley
Journal: Neurology Date: 1999-06-10 Impact factor: 9.910

4. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection.

Authors: G W Albers
Journal: Stroke Date: 1999-10 Impact factor: 7.914

5. Tissue plasminogen activator for acute ischemic stroke.

Authors:
Journal: N Engl J Med Date: 1995-12-14 Impact factor: 91.245

6. Quantitative cerebral blood flow determinations in acute ischemic stroke. Relationship to computed tomography and angiography.

Authors: A D Firlik; A M Kaufmann; L R Wechsler; K S Firlik; M B Fukui; H Yonas
Journal: Stroke Date: 1997-11 Impact factor: 7.914

7. Experimental acute thrombotic stroke in baboons.

Authors: G J Del Zoppo; B R Copeland; L A Harker; T A Waltz; J Zyroff; S R Hanson; E Battenberg
Journal: Stroke Date: 1986 Nov-Dec Impact factor: 7.914

8. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia.

Authors: E H Lo; K Matsumoto; A R Pierce; L Garrido; D Luttinger
Journal: J Cereb Blood Flow Metab Date: 1994-07 Impact factor: 6.200

9. Selective lenticulostriate occlusion in the primate. A highly focal cerebral ischemia model.

Authors: H Yonas; S K Wolfson; M Dujovny; M Boehnke; E Cook
Journal: Stroke Date: 1981 Sep-Oct Impact factor: 7.914

10. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors: W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal: JAMA Date: 1995-10-04 Impact factor: 56.272

7 in total

7. Progressive Assessment of Ischemic Injury to White Matter Using Diffusion Tensor Imaging: A Preliminary Study of a Macaque Model of Stroke.

Authors: Xiaodong Zhang; Yumei Yan; Frank Tong; Chun-Xia Li; Benjamin Jones; Silun Wang; Yuguang Meng; E Chris Muly; Doty Kempf; Leonard Howell
Journal: Open Neuroimag J Date: 2018-03-30

7 in total

Model of reversible cerebral ischemia in a monkey model.

1. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

2. The distribution and density of reduced cerebral blood flow following acute middle cerebral artery occlusion: an experimental study by the technique of hydrogen clearance in baboons.

3. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.

4. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection.

5. Tissue plasminogen activator for acute ischemic stroke.

6. Quantitative cerebral blood flow determinations in acute ischemic stroke. Relationship to computed tomography and angiography.

7. Experimental acute thrombotic stroke in baboons.

8. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia.

9. Selective lenticulostriate occlusion in the primate. A highly focal cerebral ischemia model.

10. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1. Sodium MRI and the assessment of irreversible tissue damage during hyper-acute stroke.

2. An Enhanced Model of Middle Cerebral Artery Occlusion in Nonhuman Primates Using an Endovascular Trapping Technique.

3. Endovascular Ischemic Stroke Models in Nonhuman Primates.

4. MAP2 immunostaining in thick sections for early ischemic stroke infarct volume in non-human primate brain.

5. Imaging Stroke Evolution after Middle Cerebral Artery Occlusion in Non-human Primates.

Review 6. An Evidence-Based Review of Related Metabolites and Metabolic Network Research on Cerebral Ischemia.

7. Progressive Assessment of Ischemic Injury to White Matter Using Diffusion Tensor Imaging: A Preliminary Study of a Macaque Model of Stroke.